Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Washington

205 recruiting clinical trials across 15 cities in Washington (WA). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
205
Total Trials
205
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Washington

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00756665

Prostate Active Surveillance Study

The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance...

Sponsor: University of WashingtonEnrolling: 300011 locations
Prostatic Neoplasms
RECRUITINGNCT01694940

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Sponsor: Columbia UniversityEnrolling: 100017 locations
Mitochondrial DisordersMitochondrial Genetic DisordersMitochondrial Diseases+2
RECRUITINGNCT01703429

Complementary and Alternative Care in Multiple Sclerosis

This is a prospective, observational study designed to describe disease progression, symptom change, quality of life, diet and lifestyle habits, and frequency of adverse events...

Sponsor: Bastyr UniversityEnrolling: 10001 location
Multiple Sclerosis
RECRUITINGPhase 1 / Phase 2NCT02140255

Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 112020 locations
HIV Infection
RECRUITINGPhase 1 / Phase 2NCT02343042

Selinexor and Backbone Treatments of Multiple Myeloma Patients

This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of...

Sponsor: Karyopharm Therapeutics INCEnrolling: 30020 locations
Multiple Myeloma
RECRUITINGNCT02432560

Safety and Durability of Sirolimus for Treatment of LAM

The MIDAS study aims to follow male and female LAM patients who are currently taking, have previously failed or been intolerant of, or may (at some time in the future) take mTOR...

Sponsor: University of CincinnatiEnrolling: 60020 locations
Lymphangioleiomyomatosis
RECRUITINGPhase 3NCT03016819

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma...

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study...

Sponsor: Advenchen Laboratories, LLCEnrolling: 32520 locations
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
Age-Related Macular Degeneration
RECRUITINGNCT03256240

Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

This study proposes a randomized prospective study comparing the Kono-S anastomosis to the standard side-to-side anastomosis.This will be a multi-center randomized prospective...

Sponsor: Weill Medical College of Cornell UniversityEnrolling: 60015 locations
Crohn's Disease
RECRUITINGPhase 1NCT03326921

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor...

This phase I trial studies the side effects and best dose of CD4+ and CD8+ HA-1 T cell receptor (TCR) (HA-1 T TCR) T cells in treating patients with acute leukemia that persists,...

Sponsor: Fred Hutchinson Cancer CenterEnrolling: 241 location
Juvenile Myelomonocytic LeukemiaRecurrent Acute Biphenotypic LeukemiaRecurrent Acute Undifferentiated Leukemia+26
RECRUITINGPhase 3NCT03401398

Stress Hydrocortisone In Pediatric Septic Shock

SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive...

Sponsor: Jerry ZimmermanEnrolling: 50020 locations
Septic Shock
RECRUITINGPhase 2 / Phase 3NCT03474029

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

This study is conducted to compare the safety and effectiveness of a novel short 6-week regimen of daily rifapentine (6wP, experimental arm) with a comparator arm of 12-16 weeks...

Sponsor: Centers for Disease Control and PreventionEnrolling: 340016 locations
Latent Tuberculosis
RECRUITINGPhase 3NCT03592472

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma...

This is a randomized, Phase 3, double-blind, placebo-controlled study of pazopanib plus abexinostat versus pazopanib plus placebo in patients with locally advanced unresectable or...

Sponsor: Xynomic Pharmaceuticals, INC.Enrolling: 41320 locations
Renal Cell Carcinoma
RECRUITINGNCT03604835

Mucopolysaccharidosis VII Disease Monitoring Program

The objectives of this study are to characterize MPS VII disease presentation and progression and assess long-term effectiveness and safety, including hypersensitivity reactions...

Sponsor: Ultragenyx Pharmaceutical INCEnrolling: 5014 locations
Mucopolysaccharidosis VIIMPS VIIMPS 7+1
RECRUITINGPhase 1 / Phase 2NCT03761108

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of linvoseltamab to give to patients with multiple myeloma and...

Sponsor: Regeneron PharmaceuticalsEnrolling: 38720 locations
Multiple Myeloma
RECRUITINGPhase 4NCT03781752

Carboxylesterase 1 Genetic Variation and Methylphenidate in ADHD

The study team will determine the association between d,l-methylphenidate (MPH) therapeutic outcomes in ADHD patients and genetic variants of CES1 and reveal key associations...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 5004 locations
ADHDAttention Deficit Hyperactivity Disorder
RECRUITINGNCT03877796

Clinical Pre-screening Protocol for Ovarian Cancer

The patient's local archival tumor tissue (FFPE) from original tumor, or from the metastatic tissue, will be collected to potentially identify if they - at a later stage of their...

Sponsor: Allarity TherapeuticsEnrolling: 605 locations
Ovarian Cancer
RECRUITINGPhase 4NCT03987763

A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis

This study is to evaluate the safety, the systemic exposure of halobetasol propionate (HP), and the hypothalamic-pituitary-adrenal (HPA) axis suppression potential for topically...

Sponsor: Bausch Health Americas, Inc.Enrolling: 459 locations
Psoriasis
RECRUITINGPhase 3NCT04047628

Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)

This is a multi-center prospective rater-masked (blinded) randomized controlled trial of 156 participants, comparing the treatment strategy of Autologous Hematopoietic Stem Cell...

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Enrolling: 15620 locations
Relapsing Multiple SclerosisRelapsing Remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
RECRUITINGNCT04098445

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 20009 locations
Hematopoietic Stem Cell Transplant (HSCT)Diffuse Alveolar HemorrhageThrombotic Microangiopathies+2
RECRUITINGNCT04101968

The GBA Multimodal Study in Parkinson's Disease

This study plans to analyze the molecular and clinical mechanisms of the relationship between the GBA mutations and Parkinson's disease. This will be assessed through the use of...

Sponsor: Pacific Parkinson's Research CentreEnrolling: 253 locations
Parkinson DiseaseGBA Gene MutationGaucher Disease
RECRUITINGPhase 1 / Phase 2NCT04104776

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients...

Sponsor: Novartis PharmaceuticalsEnrolling: 27520 locations
Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5
RECRUITINGNCT04131036

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

The investigators propose to study longitudinal joint and bone density changes in patients with severe Hemophilia A. Per current standard of care, most patients are on...

Sponsor: Washington Institute for CoagulationEnrolling: 404 locations
Hemophilia A
RECRUITINGPhase 2NCT04175431

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer,...

This phase II trial studies how well prostate specific membrane antigen (PSMA) or fluciclovine positron emission tomography (PET)/computed tomography (CT) site-directed therapy...

Sponsor: University of WashingtonEnrolling: 1002 locations
Prostate Adenocarcinoma
RECRUITINGPhase 2NCT04282187

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative...

This phase II trial studies how well decitabine with ruxolitinib, fedratinib, or pacritinib works before hematopoietic stem cell transplant in treating patients with...

Sponsor: University of WashingtonEnrolling: 251 location
Acute Myeloid LeukemiaEssential ThrombocythemiaMyelodysplastic Syndrome+6
RECRUITINGPhase 1NCT04294043

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source...

Sponsor: Chris GossEnrolling: 4010 locations
Nontuberculous Mycobacterium Infection
RECRUITINGNCT04431479

Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study

This trial collects clinical data and blood samples to predict the quality of response to specific treatments in patients with chronic graft-versus-host disease (cGVHD) who are...

Sponsor: Fred Hutchinson Cancer CenterEnrolling: 30010 locations
Chronic Graft Versus Host Disease
RECRUITINGPhase 2 / Phase 3NCT04442022

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With...

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive...

Sponsor: Karyopharm Therapeutics INCEnrolling: 50120 locations
Relapsed/Refractory Diffuse Large B-cell Lymphoma
RECRUITINGNCT04472338

Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study

This study investigates ways to detect prostate cancer earlier in people at genetic risk for disease that forms, grows, or spreads quickly (aggressive). Studying samples of blood,...

Sponsor: University of WashingtonEnrolling: 4508 locations
Prostate Carcinoma
RECRUITINGNCT04512755

AIMS Medical Outcomes Study

This epidemiologic research is being conducted as an observational prospective case series outcomes study of the use of advanced integrative specialty medical care and its effect...

Sponsor: Advanced Integrative Medical Science InstituteEnrolling: 5001 location
Mental Health IssuePTSDPain+2

Showing 30 of 205 trials in Washington. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 205 clinical trials actively recruiting participants in Washington. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Washington include Ovarian Cancer, Multiple Myeloma, Colorectal Cancer, Multiple Sclerosis, Renal Cell Carcinoma. Each has multiple active trials across research centers in the state.

Major trial sites in Washington include Seattle, Spokane, Tacoma, Bellevue, Everett. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.